Alexandra Sundermann

Has grant

Assistant Professor

Vanderbilt University Medical Center
Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

About

Alexandra Sundermann is an Assistant Professor at Vanderbilt University Medical Center in the United States. Her research areas focus on maternal morbidity and mortality, particularly among cancer patients at the time of delivery, as well as the effects of alcohol consumption during pregnancy. Recent publications include studies on maternal alcohol metabolism, genotype associations with miscarriage, and prospective cohort studies on alcohol consumption and spontaneous abortion risk.

Recent Grants

Grant: Close

Examining Complex Relationships Between Alcohol Exposure and Miscarriage Risk

Open Date: 2018-02-01

Close Date: 2020-05-01

Articles (12)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

38 Background: Despite the increasing number of adults diagnosed with, treated for, and surviving colorectal cancer (CRC) within their child-bearing years, reproductive health counseling and CRC-related infertility treatment remain an unmet clinical care need. We documented the current use of fertility preservation (FP) services among commercially-insured adults diagnosed with early-onset CRC in the United States. Methods: We analyzed patient-level healthcare claims data for reproductive-age males and females (18-42 years) diagnosed with CRC between 2016-2022 in the national MarketScan Commercial Encounters Database. Incident CRC was identified using international classification of disease (ICD)-O-3 diagnosis codes (1 inpatient claim with diagnosis codes or 2 outpatient claims with diagnosis codes incurred 42 days apart). Current procedural terminology (CPT) and Healthcare Common Procedure Coding System (HCPCS) standardized billing codes were used to capture CRC treatment(s) and FP services—inclusive of consultation services, laboratory testing, ultrasound monitoring, in vitro fertilization (IVF) procedures, FP medications and pre-implantation genetic testing. Primary outcomes were the use of and time to FP services after CRC diagnosis. Multivariable Poisson regressions were used to estimate relative risks (RRs) and 95% confidence intervals (CI) for documented use of FP services. Results: Among 1,966 early-onset CRC patients (male: 49.2%, mean age: 36.9 years) with at least 1 year of pre- and post-CRC diagnosis follow-up, 8.2% (n=161) had any documented use of FP services after diagnosis. A total of 3.6% (n=71) of patients had a fertility consultation, 2.8% (n=55) had laboratory testing, 2.1% (n=42) had ultrasound monitoring, 3.6% (n=70) had IVF laboratory procedures, 1.9% (n=37) had fertility medications and 0.1% (n<10) had pre-implantation genetic testing. Receipt of fertility counseling was lower among patients diagnosed with colon (RR 0.58, 95% CI 0.35-0.96, P=0.03) relative to rectal cancer, and among male (RR 0.27, 95% CI 0.15-0.47, P<0.001) relative to female patients in models adjusted for CRC diagnosis age and year, health plan type, area of residence, Census region, and CRC treatment. Specific to patients who underwent CRC treatment and had a fertility consultation (n=67), only 31.1% (n=21) received fertility consultation prior to initiation of CRC treatment. The median time from CRC treatment to fertility consultation was 92 days (range: 3-2,027). Conclusions: Fewer than one in every 10 commercially-insured patients with early-onset CRC in the United States had any documented use of FP services as reimbursed through their commercial insurance plan. Further investigation into the potential barriers for FP services among reproductive-age CRC patients is needed to facilitate delivery of concordant reproductive healthcare to this growing population.

Year:

2026

OBJECTIVE: To identify determinants of selected pregnancy testing behaviors among pregnancy planners and to elucidate the relationship between pregnancy testing and detection. METHODS: In PRESTO (Pregnancy Study Online), a North American prepregnancy cohort study of pregnancy planners (2018–2024), participants reported day-specific information about pregnancy testing spanning 4 days before day of expected menstruation through 4 days after. We used generalized linear models to estimate the association between maternal attributes and pregnancy testing behavior, characterized as the timing of the first test and testing frequency. We used quantile regression to estimate the timing of pregnancy detection among participants who conceived by maternal characteristics and pregnancy testing behavior. We estimated the adjusted risk of having a negative test result and the probability of detecting a very early pregnancy loss by the timing of the pregnancy test. RESULTS: We analyzed data from 20,458 pregnancy tests across 6,569 unique participants. Of the participants, 40.7% of reported they engaged in very early testing , defined as testing more than 4 days before their expected period. We observed a range of pregnancy testing intensity, with some participants testing only once and others testing every day. Among participants who detected pregnancy, very early testers were more than 5 times more likely to have a negative test result before a positive test result than those who waited until the day of expected period to test (adjusted risk ratio [aRR[ 5.89; 95% CI, 4.73–7.33). Very early testers were more than 3 times more likely to have an initial positive test result followed by a negative test result, likely reflecting increased detection of very early pregnancy losses (aRR 3.80; 95% CI, 2.12–6.80). CONCLUSION: Patterns in home pregnancy testing varied widely among pregnancy planners. Early initiation of pregnancy testing was associated with slightly earlier pregnancy detection, but also a marked increase in risk of negative test results and detection of very early pregnancy losses.

Year:

2026

OBJECTIVE: To estimate the risk associated with discrepancies between last menstrual period (LMP)–based and ultrasound-based gestational dating and pregnancy loss in a prospective cohort of individuals of normal fertility who underwent standardized early-pregnancy ultrasonography. METHODS: Participants in a community-based, prospective pregnancy cohort were recruited preconceptionally or in early pregnancy. Participants underwent standardized research ultrasonography targeted for the sixth week of gestation. We calculated the magnitude of lag between ultrasound-based age and LMP-based age at the research ultrasonogram. Cox proportional-hazards models were used to estimate the association between this difference and pregnancy loss. To assess for effect modification, analyses were stratified by week of research ultrasonogram, developmental features observed on the ultrasonogram, and menstrual regularity. RESULTS: Among 4,935 participants, the median difference between LMP-based and ultrasound-based gestational age on the research ultrasonogram was 1 day (interquartile range −1 to 5 days), and 9.3% of pregnancies ended in loss. Risk of pregnancy loss increased exponentially with each additional day ultrasound-based dating lagged LMP-based dating ( P <.001). This association persisted when stratified by week of ultrasonography and was more pronounced among pregnancies with a measurable crown–rump length. Ultrasound-based gestational age lagging LMP-based gestational age by more than 3 days was associated with a fivefold increased risk of pregnancy loss (adjusted hazard ratio [HR] 5.34, 95% CI, 4.37–6.52), and a lag of more than 5 days was associated with a greater than sixfold increased risk (adjusted HR 6.99, 95% CI, 5.78–8.44). These findings persisted when analyses were restricted to individuals with regular cycles and certain LMP dates. CONCLUSION: Increasing lag between ultrasound-based dating and LMP-based dating among asymptomatic patients was strongly associated with pregnancy loss risk. This clinically quantifiable measure can inform concern for pregnancy loss before symptom onset among individuals with a certain LMP.

Year:

2025

INTRODUCTION: Bleeding is a common and distressing symptom in early pregnancy. Although most pregnancies with first-trimester bleeding result in live birth, the association between symptom timing and miscarriage risk is unknown. METHODS: Participants in a community-based prospective pregnancy cohort were recruited prior to conception or in early pregnancy. Participants provided information on timing, duration, and frequency of bleeding episodes in early pregnancy. Bleeding episodes that ended less than 4 days before a miscarriage were excluded from the analysis. Participants underwent a study ultrasound targeted for 6 weeks of gestation. We used Cox proportional hazards models to quantify the association between first-trimester bleeding and miscarriage risk and to assess whether risk was modified by gestational age at bleeding episode or features observed on standardized study ultrasound. RESULTS: Among 5,425 participants, 25.0% reported at least one episode of first-trimester bleeding and 12.0% of pregnancies ended in miscarriage. Bleeding was not associated with an overall risk of miscarriage (hazard ratio [HR] 0.93; 95% CI, 0.77–1.11). Only bleeding in week 9 of pregnancy was associated with an independent increase in miscarriage risk (HR 1.72; 95% CI, 1.14–2.60). First-trimester bleeding coupled with a greater than 4-day difference in observed versus expected features on ultrasound was associated with a fourfold increased risk of miscarriage (HR 4.21; 95% CI, 3.11–5.70). CONCLUSIONS/IMPLICATIONS: Implications of first-trimester bleeding for miscarriage risk are tied to gestational age at bleeding episode and features observed on ultrasound. This information can guide more specific patient counseling concerning risk.

Year:

2025

Year:

2025

Year:

2023

Year:

2022

Year:

2021

Collaborators (2)

Digna R. Velez Edwards

Vanderbilt University Medical Center

UNITED STATES
View details

Michelle Liu

Vanderbilt University Medical Center

UNITED STATES
View details